These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 17111028
1. Effect of fasudil on macrovascular disorder-induced endothelial dysfunction. Shah DI, Singh M. Can J Physiol Pharmacol; 2006; 84(8-9):835-45. PubMed ID: 17111028 [Abstract] [Full Text] [Related]
2. Involvement of Rho-kinase in experimental vascular endothelial dysfunction. Shah DI, Singh M. Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602 [Abstract] [Full Text] [Related]
3. Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats. Shah DI, Singh M. Fundam Clin Pharmacol; 2006 Dec; 20(6):595-604. PubMed ID: 17109653 [Abstract] [Full Text] [Related]
4. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats. Shah DI, Singh M. Mol Cell Biochem; 2007 Jan; 295(1-2):65-74. PubMed ID: 16841179 [Abstract] [Full Text] [Related]
5. Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction. Shah DI, Singh M. Int J Cardiol; 2007 Sep 03; 120(3):317-24. PubMed ID: 17240464 [Abstract] [Full Text] [Related]
6. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat. Chakkarwar VA. Vascul Pharmacol; 2011 Sep 03; 55(5-6):163-8. PubMed ID: 21864717 [Abstract] [Full Text] [Related]
7. Activation of protein kinase A improves vascular endothelial dysfunction. Shah DI, Singh M. Endothelium; 2006 Sep 03; 13(4):267-77. PubMed ID: 16990183 [Abstract] [Full Text] [Related]
8. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction. Jyoti U, Kansal SK, Kumar P, Goyal S. Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb 03; 389(2):167-75. PubMed ID: 26497187 [Abstract] [Full Text] [Related]
9. Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats. Tsounapi P, Saito M, Kitatani K, Dimitriadis F, Ohmasa F, Shimizu S, Kinoshita Y, Takenaka A, Satoh K. Eur J Pharmacol; 2012 Sep 15; 691(1-3):182-9. PubMed ID: 22819709 [Abstract] [Full Text] [Related]
10. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A. Circ Res; 2003 Oct 17; 93(8):767-75. PubMed ID: 14500337 [Abstract] [Full Text] [Related]
11. Beneficial effect of insulin in hyperhomocysteinemia and diabetes mellitus-induced vascular endothelium dysfunction: role of phosphoinositide dependent kinase and protein kinase B. Sharma S, Singh M, Sharma PL. Mol Cell Biochem; 2011 Feb 17; 348(1-2):21-32. PubMed ID: 21069435 [Abstract] [Full Text] [Related]
12. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat. Balakumar P, Sharma R, Singh M. Pharmacol Res; 2008 Feb 17; 58(5-6):356-63. PubMed ID: 18951979 [Abstract] [Full Text] [Related]
13. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction. Shah DI, Singh M. Vascul Pharmacol; 2006 Mar 17; 44(3):177-82. PubMed ID: 16442349 [Abstract] [Full Text] [Related]
15. Long term Rho-kinase inhibition ameliorates endothelial dysfunction in LDL-Receptor deficient mice. Steioff K, Rütten H, Busch AE, Plettenburg O, Ivashchenko Y, Löhn M. Eur J Pharmacol; 2005 Apr 11; 512(2-3):247-9. PubMed ID: 15840411 [Abstract] [Full Text] [Related]
16. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase. Hofni A, Shehata Messiha BA, Mangoura SA. Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug 11; 390(8):801-811. PubMed ID: 28493050 [Abstract] [Full Text] [Related]
17. Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction. Shah DI, Singh M. Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun 11; 373(3):221-9. PubMed ID: 16736159 [Abstract] [Full Text] [Related]
18. Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B. Sharma S, Singh M, Sharma PL. Eur J Pharmacol; 2013 Dec 05; 721(1-3):365-72. PubMed ID: 24021535 [Abstract] [Full Text] [Related]
19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G. Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975 [Abstract] [Full Text] [Related]